On Jan. 25 2023, Seqalis broadcasted a live expert panel on immuno-oncology and quantitative TCR sequencing. The webinar was organized by Seqalis with the collaboration of the Institut de Duve (UCLouvain, Be) and PDC-Line Pharma (Be/Fr).
The expert panel was composed of Dr Sophie Lucas, President of de Duve Institute (UCLouvain, Be), Eric Halioua, CEO of PDC-Line Pharma (Fr/Be), Dr Joël Plumas, CSO of PDC-Line Pharma (Be/Fr) and Dr Javier Carrasco, clinical oncologist at the Grand Hôpital de Charleroi (Be) and Medical Advisor of Seqalis.
The webinar turned out to be an overwhelming success thanks to the very high quality of both the experts’ presentations and the insightful questions coming from the audience.
We sincerely hope that such a webinar will trigger new, innovative and disruptive approaches within the immunotherapy research and clinical trial community.
(Re)watch & Share
We have recorded the input of our experts, so one can refer back to it. We invite you to share the recording with colleagues to inspire their day-to-day basic and clinical research work.
